|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Multiple-dose pharmacokinetics,pharmacodynamics and safety of atorvastatin,an inhibitor of HMG-CoA reductase,in healthy subjects显示文摘 | Whitfield LR Gibson DM | 1996 | Clin Pharmacol Ther1996，60，6： | 1 |
| 2 | Multipledose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reduetase, in healthy subjects 显示文摘 | CILLA DD WHITEFIELD LR GIBSON DM | 1996 | Clin Pharmacol Ther1996，60，6： | 1 |
| 3 | Infuce of day and night temertrue on soybeen seed 显示文摘 | Gibson LR and RE Mullen | 1996 | Crop Science1996，，36： | 1 |
| 4 | Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening显示文摘 | Gibson DM Whitfield LR | 1996 | Clin Pharmacol1996，36，7： | 1 |
| 5 | Multiple-dose pharmacokinetics,pharmacodynamics,and safety of torvastatin,an inhibitor of HMG-CoA reductase,in healthy subjects显示文摘 | Cilla DD Jr Whitfield LR Gibson DM | 1996 | Clin Pharmacol Ther1996，60，6： | 1 |
| 6 | Mutiple-dose pharmacokinetics, pharmacodinamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects 显示文摘 | Cilla DD Whitfield LR Gibson DM | 1996 | J Clin Pharmacol1996，60，6： | 1 |
| 7 | Multiple-dose pharmacokinetics,pharmacodynamics,and safety of atorvastatin,an inhibitor of HMG-CoA reductase,in healthy subjects显示文摘 | Cilla DD Whitfield LR Gibson DM | 1996 | Clin Pharmacol Ther1996，60，： | 1 |
| 8 | Planting date effects on winter triti- cale grain yield and yield components 显示文摘 | AJ Schwarte LR Gibson DL Karlen PM Dixon M Liebman JL Jannink | 2006 | Crop Science2006，46，3： | 1 |
| 9 | Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening显示文摘 | Cilla DD Jr Gibson DM Whitfield LR Sedman AJ | 1996 | J Clin Pharmacol1996，36，： | 1 |
| 10 | Pharmacodyna-mic effects and pharmacokinetics of atorvastatin after adminis-tration to normocholesterolemic subjects in the morning andevening 显示文摘 | Cilla Jr DD Gibson DM Whitfield LR | 1996 | Clin Pharmacol1996，36，7： | 1 |
| 11 | ECOG2205: A phase Ⅱ study to measure response rate and toxicity of neo-adjuvant chemoradiotherapy (CRT) ( IMRT permitted)with oxaliplatin (O) and infusional 5-fluorouracil ( 5-FU ) plus eetuximab ( C225 ) followed by postoperative docetaxel (DT) and C in patients with operable adenocarcinoma of the esophagus : high risk of post-op adult respriratory distress syndrome(ARDS) 显示文摘 | Kleinberg LR Catalano PJ Gibson CA | 2010 | J Clin Oncol2010，78，3： | 1 |
| 12 | Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects显示文摘 | Cilla DD Jr Whiffield LR Gibson DM | 1996 | Clin Pharmacol Ther1996，60，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员